Copyright
©The Author(s) 2016.
World J Gastroenterol. Jun 21, 2016; 22(23): 5364-5373
Published online Jun 21, 2016. doi: 10.3748/wjg.v22.i23.5364
Published online Jun 21, 2016. doi: 10.3748/wjg.v22.i23.5364
Figure 3 miR-548a-5p promotes hepatocellular carcinoma cell proliferation in vitro and in vivo.
A: CCK-8 assays of HepG2 and MHCC97H cells constantly expressing miR-548a-5p or miR-control; B: Colony forming assays of HepG2 and MHCC97H cells constantly expressing miR-548a-5p or miR-control; C: Cell cycle assays of HepG2 and MHCC97H cells constantly expressing miR-548a-5p or miR-control; D: MiR-548a-5p or miR-control overexpressing HepG2 cells were injected into the subcutaneous layer of nude mice. The mice were killed 30 d after injection; E: Tumor volumes and weight. aP < 0.05, bP < 0.01 vs control.
- Citation: Zhao G, Wang T, Huang QK, Pu M, Sun W, Zhang ZC, Ling R, Tao KS. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737. World J Gastroenterol 2016; 22(23): 5364-5373
- URL: https://www.wjgnet.com/1007-9327/full/v22/i23/5364.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i23.5364